Prevention of preeclampsia with aspirin

DL Rolnik, KH Nicolaides, LC Poon - American journal of obstetrics and …, 2022 - Elsevier
Preeclampsia is defined as hypertension arising after 20 weeks of gestational age with
proteinuria or other signs of end-organ damage and is an important cause of maternal and …

First trimester preeclampsia screening and prediction

P Chaemsaithong, DS Sahota, LC Poon - American journal of obstetrics …, 2022 - Elsevier
Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. Early-onset
disease requiring preterm delivery is associated with a higher risk of complications in both …

The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice

LA Magee, MA Brown, DR Hall, S Gupte… - Pregnancy …, 2022 - Elsevier
All units managing hypertensive pregnant women should maintain and review uniform
departmental management protocols and conduct regular audits of maternal & fetal …

[HTML][HTML] The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and …

LC Poon, A Shennan, JA Hyett, A Kapur… - … of gynaecology and …, 2019 - ncbi.nlm.nih.gov
Preeclampsia (PE) is a multisystem disorder that typically affects 2%− 5% of pregnant
women and is one of the leading causes of maternal and perinatal morbidity and mortality …

Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

MY Tan, A Syngelaki, LC Poon… - … in Obstetrics & …, 2018 - Wiley Online Library
Objective To examine the performance of screening for early, preterm and term pre‐
eclampsia (PE) at 11–13 weeks' gestation by maternal factors and combinations of mean …

The competing risk approach for prediction of preeclampsia

D Wright, A Wright, KH Nicolaides - American journal of obstetrics and …, 2020 - Elsevier
The established method of the assessment of the risk for development of preeclampsia is to
identify risk factors from maternal demographic characteristics and medical history; in the …

Antiplatelet agents for preventing pre‐eclampsia and its complications

L Duley, S Meher, KE Hunter… - … of systematic reviews, 2019 - cochranelibrary.com
Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population

P Chaemsaithong, RK Pooh, M Zheng, R Ma… - American journal of …, 2019 - Elsevier
Background The administration of aspirin< 16 weeks gestation to women who are at high
risk for preeclampsia has been shown to reduce the rate of preterm preeclampsia by 65 …

Predictive performance of the competing risk model in screening for preeclampsia

D Wright, MY Tan, N O'Gorman, LC Poon… - American journal of …, 2019 - Elsevier
Background The established method of screening for preeclampsia is to identify risk factors
from maternal demographic characteristics and medical history; in the presence of such …

The prediction of gestational hypertension, preeclampsia and fetal growth restriction via the first trimester screening of plasma exosomal C19MC microRNAs

I Hromadnikova, L Dvorakova, K Kotlabova… - International journal of …, 2019 - mdpi.com
The aim of the study was to verify if quantification of placental specific C19MC microRNAs in
plasma exosomes would be able to differentiate during the early stages of gestation …